SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-047628
Filing Date
2020-10-26
Accepted
2020-10-26 16:18:46
Documents
40
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mnov-10q_20200930.htm   iXBRL 10-Q 1320113
2 EX-31.1 mnov-ex311_9.htm EX-31.1 11008
3 EX-31.2 mnov-ex312_8.htm EX-31.2 11023
4 EX-32.1 mnov-ex321_6.htm EX-32.1 7903
5 EX-32.2 mnov-ex322_7.htm EX-32.2 7895
  Complete submission text file 0001564590-20-047628.txt   3569995

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA mnov-20200930.xsd EX-101.SCH 23472
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mnov-20200930_cal.xml EX-101.CAL 22237
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mnov-20200930_def.xml EX-101.DEF 65221
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnov-20200930_lab.xml EX-101.LAB 213279
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnov-20200930_pre.xml EX-101.PRE 153743
11 EXTRACTED XBRL INSTANCE DOCUMENT mnov-10q_20200930_htm.xml XML 423321
Mailing Address 4275 EXECUTIVE SQUARE SUITE 300 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 300 LA JOLLA CA 92037 858-373-1500
MEDICINOVA INC (Filer) CIK: 0001226616 (see all company filings)

IRS No.: 330927979 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33185 | Film No.: 201260915
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences